

Medrhans Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
- Paid Up Capital ₹ 2.22 Cr
- Company Age 6 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 87.24%
- Profit Growth -33.26%
- Ebitda -19.92%
- Net Worth 33.91%
- Total Assets 108.91%
About Medrhans Pharmaceuticals
Medrhans Pharmaceuticals Private Limited (MPPL) is a Private Limited Indian Non-Government Company incorporated in India on 10 December 2018 (Six years and five months 5 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 2.22 Cr, as per Ministry of Corporate Affairs (MCA) records.
Chiranjeevi Gadupudi, Venkateswarlu Nalajala, Vanga Kondalreddy, and One other member serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U74990TG2018PTC128888
- Company No.
128888
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Dec 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
What products or services does Medrhans Pharmaceuticals Private Limited offer?
Medrhans Pharmaceuticals Private Limited offers a wide range of products and services, including Sexual Wellness Products, Erectile Dysfunction Medicine, Pain Relief Drugs & Pharmaceuticals, Aceclofenac, Cardiovascular Drugs & Medication, Kidney Drugs, Common Disease Medicines, Pharmaceutical Medicine, Pharmaceutical Capsules.
Who are the key members and board of directors at Medrhans Pharmaceuticals?
Board Members (4)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Chiranjeevi Gadupudi ![]() | Director | 10-Dec-2018 | Current |
Venkateswarlu Nalajala ![]() | Director | 10-Dec-2018 | Current |
Vanga Kondalreddy ![]() | Director | 10-Dec-2018 | Current |
Gopi Bobbala ![]() | Director | 08-Jul-2019 | Current |
Financial Performance of Medrhans Pharmaceuticals.
Medrhans Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 87.24% increase. The company also saw a substantial fall in profitability, with a 33.26% decrease in profit. The company's net worth Soared by an impressive increase of 33.91%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Medrhans Pharmaceuticals?
Unlock access to Medrhans Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Charges (Loans)

There are no open charges registered against the company as per our records.
How Many Employees Work at Medrhans Pharmaceuticals?
Unlock and access historical data on people associated with Medrhans Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Medrhans Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medrhans Pharmaceuticals's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Medrhans Pharmaceuticals
Recent activity within the organization
- Annual General Meeting
Medrhans Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Balance Sheet
Medrhans Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
- Director Appointment
Gopi Krishna Bobbala was appointed as a Director was appointed as a Director on 08 Jul 2019 & has been associated with this company since 5 years 10 months .
- Director Appointment
Chiranjeevi Gadupudi was appointed as a Director was appointed as a Director on 10 Dec 2018 & has been associated with this company since 6 years 5 months .
- Director Appointment
Venkateswarlu Nalajala was appointed as a Director was appointed as a Director on 10 Dec 2018 & has been associated with this company since 6 years 5 months .
- Director Appointment
Vanga Kondalreddy was appointed as a Director was appointed as a Director on 10 Dec 2018 & has been associated with this company since 6 years 5 months .
Frequently asked questions
What is the Incorporation or founding date of Medrhans Pharmaceuticals Private Limited?
Medrhans Pharmaceuticals Private Limited was incorporated on 10 Dec 2018.
What is authorized share capital and paid-up capital of Medrhans Pharmaceuticals Private Limited?
The authorized share capital of Medrhans Pharmaceuticals Private Limited is ₹ 3.00 Cr and paid-up capital is ₹ 2.22 Cr.
Who are the current board members & directors of Medrhans Pharmaceuticals Private Limited?
Currently 4 directors are associated with Medrhans Pharmaceuticals Private Limited.
- Chiranjeevi Gadupudi
- Venkateswarlu Nalajala
- Vanga Kondalreddy
- Gopi Krishna Bobbala
What is the registered address of Medrhans Pharmaceuticals Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Medrhans Pharmaceuticals Private Limited is Plotno:91 Road No:4 Second Floor Himapuri Colony Mansoorabad, Lb Nagar India, Hyderabad, Telangana, 500068.
What is the corporate identification number (CIN) and company number of Medrhans Pharmaceuticals Private Limited?
The corporate identification number (CIN) of Medrhans Pharmaceuticals Private Limited is U74990TG2018PTC128888 and the company number is 128888 as per Ministry of Corporate Affairs (MCA).
What is the official website of Medrhans Pharmaceuticals Private Limited?
The Official website of Medrhans Pharmaceuticals Private Limited is https://www.medrhans.com
What has been the recent revenue trend for Medrhans Pharmaceuticals Private Limited?
According to the financial reports for the fiscal year 2023, the revenue trend for Medrhans Pharmaceuticals Private Limited has risen by 87.24%.
What change has been observed in the net worth of Medrhans Pharmaceuticals Private Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Medrhans Pharmaceuticals Private Limited has experienced an upsurge of 33.91%.
When was the last Balance Sheet of Medrhans Pharmaceuticals Private Limited filed with the ROC?
The most recent Balance Sheet for Medrhans Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2024.
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records